The efficacy of oral beta-carotene for the prevention of photosensitivity symptoms in erythropoietic protoporphyria was studied in a controlled cross-over trial in which it was compared with a placebo. No significant difference was found between the 2 preparations. Patients' symptoms showed statistically significant association with sunlight hour records.
No takes yet. Share an insight, caveat, or question.
Corbett et al. (1977) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: